monatepil has been researched along with Hypertension in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 6 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fukuya, F; Hosoki, K; Ikeno, A; Karasawa, T; Minato, H; Nose, I; Takeyama, K | 1 |
| Abe, K; Iimura, O; Inagaki, Y; Ishii, M; Kajiwara, N; Kuramochi, M; Kuramoto, K; Saruta, T; Yagi, S; Yoshinaga, K | 1 |
| Harano, Y; Koh, H; Kyotani, S; Nishioeda, Y; Omae, T; Suzuki, M; Tsushima, M; Waki, M | 1 |
| Arakawa, K; Kajiyama, G; Mashiba, H; Nonaka, K; Ogihara, T; Sasaki, J; Shichiri, M; Sunaga, T; Tanaka, N; Yokoyama, M | 1 |
| Fukuya, F; Honda, Y; Hosoki, K; Ikeno, A; Karasawa, T; Kataoka, T; Minato, H; Nose, I; Takeyama, K; Yamada, T | 1 |
| Fujiwara, I; Hatano, N; Honda, Y; Kurokawa, M; Mastumoto, J; Naruto, S; Sato, F; Uno, H; Yoshida, T | 1 |
2 trial(s) available for monatepil and Hypertension
| Article | Year |
|---|---|
The efficacy of monatepil, a new calcium antagonist, in the treatment of essential hypertension.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Blood Pressure; Calcium Channel Blockers; Cholesterol; Dibenzothiepins; Drug Therapy, Combination; Female; Humans; Hypertension; Male; Middle Aged; Peptidyl-Dipeptidase A; Pilot Projects; Piperazines | 1994 |
Comparative effects of monatepil, a novel calcium antagonist with alpha 1-adrenergic-blocking activity, and nitrendipine on lipoprotein and carbohydrate metabolism in patients with hypertension.
Topics: Adrenergic alpha-Antagonists; Adult; Aged; Calcium Channel Blockers; Carbohydrates; Dibenzothiepins; Humans; Hypertension; Lipoproteins; Middle Aged; Nitrendipine; Piperazines | 1994 |
4 other study(ies) available for monatepil and Hypertension
| Article | Year |
|---|---|
Antihypertensive effects of AJ-2615, a new calcium antagonist with alpha 1-adrenergic blocking activity in experimental hypertensive animals.
Topics: Adrenergic alpha-Antagonists; Animals; Antihypertensive Agents; Blood Pressure; Calcium Channel Blockers; Desoxycorticosterone; Dibenzothiepins; Diltiazem; Dogs; Female; Heart Rate; Hypertension; Hypertension, Renovascular; Male; Nicardipine; Nifedipine; Piperazines; Rats; Rats, Inbred SHR; Rats, Wistar | 1993 |
Noninvasive quantitative evaluation of early atherosclerosis and the effect of monatepil, a new antihypertensive agent. An interim report.
Topics: Aged; Antihypertensive Agents; Aorta, Abdominal; Arteriosclerosis; Calcium Channel Blockers; Carotid Arteries; Cholesterol; Dibenzothiepins; Female; Humans; Hypercholesterolemia; Hypertension; Image Processing, Computer-Assisted; Male; Middle Aged; Piperazines; Tomography, X-Ray Computed; Ultrasonography, Doppler | 1994 |
In vitro and in vivo electrocardiographic evaluation of the novel calcium antagonist monatepil on cardiac conduction system.
Topics: Anesthesia; Animals; Blood Pressure; Bundle of His; Calcium Channel Blockers; Dibenzothiepins; Diltiazem; Dogs; Electrocardiography; Female; Heart; Heart Conduction System; Heart Rate; Hypertension; In Vitro Techniques; Male; Nifedipine; Piperazines; Rabbits; Verapamil | 1993 |
A new class of calcium antagonists. 2. Synthesis and biological activity of 11-[[4-[4-(4-fluorophenyl)-1-piperazinyl]butyryl]amino]-6,11- dihydrodibenzo[b,e]-thiepin maleate and related compounds.
Topics: Animals; Aorta, Thoracic; Calcium; Calcium Channel Blockers; Chemical Phenomena; Chemistry; Chemistry, Physical; Dibenzothiepins; Heart Rate; Hypertension; Male; Methacholine Chloride; Models, Molecular; Molecular Conformation; Molecular Structure; Muscle Contraction; Muscle, Smooth, Vascular; Piperazines; Potassium; Rats; Rats, Inbred SHR; Rats, Inbred Strains; Vasoconstriction | 1991 |